APPLICATION
ANDA090367
TYPE
ANDA
ORIGINAL APPROVAL
2011-06-20
LATEST ACTION
2021-02-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LEVOFLOXACINDiscontinued
LEVOFLOXACIN 500MG · TABLET · ORAL
LEVOFLOXACINDiscontinued
LEVOFLOXACIN 750MG · TABLET · ORAL
LEVOFLOXACINDiscontinued
LEVOFLOXACIN 250MG · TABLET · ORAL
Approval history
2021-02-11Labeling · Supplement 5 · standardAP
2019-05-03Labeling · Supplement 4 · standardAP
2015-03-19Labeling · Supplement 3 · standardAP
2012-09-24Labeling · Supplement 2 · standardAP
2012-01-12Labeling · Supplement 1AP
2011-06-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.